Tuberculosis-Associated MicroRNAs: From Pathogenesis to Disease Biomarkers.

apoptosis autophagy biomarker diagnosis disease progression innate immunity latent infection microRNA pathogenesis response to therapy tuberculosis

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
24 09 2020
Historique:
received: 05 09 2020
revised: 20 09 2020
accepted: 23 09 2020
entrez: 29 9 2020
pubmed: 30 9 2020
medline: 7 4 2021
Statut: epublish

Résumé

Tuberculosis (TB) caused by

Identifiants

pubmed: 32987746
pii: cells9102160
doi: 10.3390/cells9102160
pmc: PMC7598604
pii:
doi:

Substances chimiques

Biomarkers 0
MicroRNAs 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Références

Front Microbiol. 2020 Jun 03;11:1197
pubmed: 32582115
J Infect. 2018 Oct;77(4):341-348
pubmed: 29746939
J Immunol. 2018 May 15;200(10):3506-3518
pubmed: 29661829
J Cell Mol Med. 2014 Mar;18(3):503-13
pubmed: 24373112
Trends Cell Biol. 2007 Mar;17(3):118-26
pubmed: 17197185
J Clin Invest. 2013 Nov;123(11):4836-48
pubmed: 24084739
EBioMedicine. 2017 Nov;25:112-121
pubmed: 29100778
PLoS One. 2017 Sep 14;12(9):e0184113
pubmed: 28910318
Nat Rev Immunol. 2018 Sep;18(9):575-589
pubmed: 29895826
Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17408-13
pubmed: 21969554
PLoS Pathog. 2017 May 30;13(5):e1006410
pubmed: 28558034
PLoS One. 2015 Jun 08;10(6):e0126018
pubmed: 26053546
Tuberculosis (Edinb). 2019 Sep;118:101860
pubmed: 31472444
Cell Microbiol. 2017 Jan;19(1):
pubmed: 27794209
Mol Immunol. 2015 Oct;67(2 Pt B):475-81
pubmed: 26296289
Nat Immunol. 2011 Jul 24;12(9):861-9
pubmed: 21785411
Cell Host Microbe. 2009 Oct 22;6(4):343-53
pubmed: 19837374
Tuberculosis (Edinb). 2018 Mar;109:61-68
pubmed: 29559122
Int J Clin Exp Pathol. 2015 Jan 01;8(1):655-9
pubmed: 25755759
Tuberculosis (Edinb). 2017 Jul;105:1-8
pubmed: 28610780
Tuberculosis (Edinb). 2017 Jan;102:24-30
pubmed: 28061948
Cancer Lett. 2018 Sep 1;431:22-30
pubmed: 29803788
PLoS One. 2013 Dec 05;8(12):e81076
pubmed: 24349033
FEBS Lett. 2012 Jul 30;586(16):2459-67
pubmed: 22710123
Cell Biochem Biophys. 2013;67(3):875-84
pubmed: 23559272
EBioMedicine. 2019 Feb;40:564-573
pubmed: 30745169
BMC Infect Dis. 2012 Dec 28;12:384
pubmed: 23272999
Mol Med Rep. 2016 Jun;13(6):4620-6
pubmed: 27082104
Int J Biol Sci. 2016 Jan 01;12(2):246-56
pubmed: 26884721
Proc Natl Acad Sci U S A. 2012 May 15;109(20):7853-8
pubmed: 22547807
Cell Microbiol. 2012 Oct;14(10):1620-31
pubmed: 22712528
Exp Cell Res. 2017 Sep 15;358(2):120-128
pubmed: 28606793
Sci Rep. 2016 Mar 30;6:23351
pubmed: 27025258
Int J Mol Sci. 2019 Jan 15;20(2):
pubmed: 30650615
Mol Immunol. 2013 Mar;53(3):265-9
pubmed: 22964481
Microb Pathog. 2016 Nov;100:78-83
pubmed: 27616444
Adv Drug Deliv Rev. 2015 Jun 29;87:3-14
pubmed: 25979468
Am J Respir Crit Care Med. 2018 May 1;197(9):1198-1208
pubmed: 29624071
Mol Immunol. 2011 May;48(9-10):1084-90
pubmed: 21367459
Tuberculosis (Edinb). 2018 Mar;109:41-51
pubmed: 29559120
mBio. 2020 Jan 28;11(1):
pubmed: 31992621
mBio. 2019 Dec 3;10(6):
pubmed: 31796535
J Immunol. 2015 Jun 1;194(11):5355-65
pubmed: 25917095
PLoS Pathog. 2018 Jan 4;14(1):e1006790
pubmed: 29300789
Int J Infect Dis. 2016 Feb;43:68-73
pubmed: 26724775
Front Cell Infect Microbiol. 2016 Aug 03;6:79
pubmed: 27536558
mBio. 2020 Jun 2;11(3):
pubmed: 32487755
Tuberculosis (Edinb). 2013 Nov;93(6):596-605
pubmed: 24025365
N Engl J Med. 2014 May 01;370(18):1712-1723
pubmed: 24785206
Mol Med Rep. 2015 Nov;12(5):7102-8
pubmed: 26324048
Tuberculosis (Edinb). 2017 Dec;107:48-58
pubmed: 29050771
Nat Commun. 2018 Oct 16;9(1):4295
pubmed: 30327467
Nat Immunol. 2016 Jun;17(6):677-86
pubmed: 27089382
Front Microbiol. 2018 Mar 29;9:602
pubmed: 29651283
Sci Rep. 2016 Feb 25;6:22041
pubmed: 26912204
Epigenomics. 2018 Aug;10(8):1051-1069
pubmed: 30052058
Autophagy. 2017 Feb;13(2):423-441
pubmed: 27764573
Infect Immun. 2020 Feb 20;88(3):
pubmed: 31871103
Science. 2010 May 14;328(5980):856-61
pubmed: 20466923
Genet Mol Res. 2015 Dec 17;14(4):17235-43
pubmed: 26681217
Mol Immunol. 2019 Aug;112:103-114
pubmed: 31082644
Tuberculosis (Edinb). 2015 May;95(3):246-50
pubmed: 25846955
Clin Dev Immunol. 2011;2011:814943
pubmed: 21234341
Nat Immunol. 2015 Jan;16(1):57-63
pubmed: 25521685
Mol Immunol. 2014 Nov;62(1):29-36
pubmed: 24937178
EMBO Mol Med. 2015 Dec 18;8(2):86-95
pubmed: 26682570
PLoS Pathog. 2013;9(10):e1003697
pubmed: 24130493
Science. 2010 Jun 18;328(5985):1570-3
pubmed: 20466885
J Biol Chem. 2013 Feb 15;288(7):5056-61
pubmed: 23233675
Int Immunol. 2014 Oct;26(10):579-82
pubmed: 24981709
Dis Markers. 2019 Feb 11;2019:1907426
pubmed: 30886653
PLoS One. 2011;6(10):e25832
pubmed: 22003408
Cell Host Microbe. 2015 Mar 11;17(3):345-356
pubmed: 25683052
Front Immunol. 2018 Apr 13;9:661
pubmed: 29706954
Clin Microbiol Rev. 2003 Jul;16(3):463-96
pubmed: 12857778
Nat Rev Microbiol. 2010 Sep;8(9):668-74
pubmed: 20676146
Tuberculosis (Edinb). 2013 Nov;93(6):606-11
pubmed: 24053976
PLoS One. 2014 Feb 20;9(2):e88909
pubmed: 24586438
Nature. 2008 Feb 28;451(7182):1125-9
pubmed: 18278031
Nat Commun. 2020 May 8;11(1):2270
pubmed: 32385301
Mol Cell Biol. 2012 Jun;32(12):2239-53
pubmed: 22473996
Brain Res Bull. 2017 Apr;130:231-235
pubmed: 28109794
Tuberculosis (Edinb). 2011 Sep;91(5):427-31
pubmed: 21550855
J Immunol. 2014 Nov 1;193(9):4537-47
pubmed: 25252958
Lancet Respir Med. 2016 Mar;4(3):213-24
pubmed: 26907218
Science. 1991 Oct 11;254(5029):277-9
pubmed: 1925582
Nat Med. 2012 Jan 29;18(2):267-73
pubmed: 22286305
PLoS One. 2013 Apr 16;8(4):e61609
pubmed: 23613882
Front Immunol. 2019 Sep 11;10:2139
pubmed: 31572365
J Clin Microbiol. 2011 Dec;49(12):4246-51
pubmed: 21998423
Tuberculosis (Edinb). 2015 Jul;95(4):395-403
pubmed: 25936536
Eur Respir J. 2015 Apr;45(4):1173-6
pubmed: 25657026
PLoS One. 2013 Nov 21;8(11):e80149
pubmed: 24278252
Nat Rev Immunol. 2012 Jul 13;12(8):581-91
pubmed: 22790178
Cell Host Microbe. 2018 Jul 11;24(1):34-42
pubmed: 30001523
Trends Immunol. 2009 Aug;30(8):383-91
pubmed: 19643665
J Cell Biochem. 2019 Apr;120(4):5889-5896
pubmed: 30378171
Annu Rev Pathol. 2012;7:353-84
pubmed: 22054143
Front Microbiol. 2019 May 28;10:1174
pubmed: 31191492
Cell Physiol Biochem. 2015;35(4):1276-88
pubmed: 25721573
Lancet. 2016 Jun 4;387(10035):2312-2322
pubmed: 27017310
Tuberculosis (Edinb). 2019 May;116:37-43
pubmed: 31153517
Tuberculosis (Edinb). 2016 Jul;99:63-9
pubmed: 27450007
Proc Natl Acad Sci U S A. 2016 Oct 11;113(41):E6172-E6181
pubmed: 27681624
Science. 2010 Jun 18;328(5985):1566-9
pubmed: 20466882
PLoS Med. 2019 May 24;16(5):e1002814
pubmed: 31125334
Tuberculosis (Edinb). 2019 Jan;114:69-76
pubmed: 30711160
Nat Immunol. 2010 Sep;11(9):799-805
pubmed: 20711193
Lancet. 2016 Jun 4;387(10035):2268-2270
pubmed: 27017311
Tuberculosis (Edinb). 2018 Jan;108:26-34
pubmed: 29523324
EBioMedicine. 2017 Feb;15:112-126
pubmed: 28065665
Cell Rep. 2020 Jan 7;30(1):124-136.e4
pubmed: 31914380
Eur Respir J. 2015 Jun;45(6):1741-4
pubmed: 25745052
Tuberculosis (Edinb). 2017 Jul;105:73-79
pubmed: 28610790
Nat Rev Dis Primers. 2016 Oct 27;2:16076
pubmed: 27784885
Lancet Infect Dis. 2018 Jul;18(7):e199-e210
pubmed: 29580818
Gene. 2018 May 20;655:35-41
pubmed: 29477867
FEBS Lett. 2014 Nov 17;588(22):4140-7
pubmed: 25128459

Auteurs

Alessandro Sinigaglia (A)

Department of Molecular Medicine, University of Padova, 35121 Padova, Italy.

Elektra Peta (E)

Department of Molecular Medicine, University of Padova, 35121 Padova, Italy.

Silvia Riccetti (S)

Department of Molecular Medicine, University of Padova, 35121 Padova, Italy.

Seshasailam Venkateswaran (S)

School of Chemistry, Kings Buildings, The University of Edinburgh, Edinburgh EH9 3FJ, UK.

Riccardo Manganelli (R)

Department of Molecular Medicine, University of Padova, 35121 Padova, Italy.

Luisa Barzon (L)

Department of Molecular Medicine, University of Padova, 35121 Padova, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH